Norwegian PSC Research Center, Clinic for Specialized Medicine and Surgery, Oslo University Hospital, Rikshospitalet, 0027 Oslo, Norway.
Best Pract Res Clin Gastroenterol. 2011 Dec;25(6):713-26. doi: 10.1016/j.bpg.2011.09.010.
Primary sclerosing cholangitis (PSC) is a chronic and severe inflammatory disease leading to fibrotic bile duct destruction and in most cases liver cirrhosis. As in other complex genetic diseases, the sibling risk of PSC is more than ten times that of the general population. Recent genome-wide association studies have consistently identified several genetic susceptibility loci. The overlap of these loci with susceptibility loci in other chronic inflammatory diseases is considerable, and offers intriguing opportunities for transfer of pathogenetic knowledge and potentially treatment options. In the present article we summarise the present knowledge on PSC genetics with a particular emphasis on the major histocompatibility complex (MHC). We discuss the clinical relevance of the risk loci and elaborate on the insight that may be obtained from associated inflammatory conditions and existing murine knock-out models.
原发性硬化性胆管炎(PSC)是一种慢性且严重的炎症性疾病,可导致纤维性胆管破坏,在大多数情况下还会导致肝硬化。与其他复杂的遗传疾病一样,PSC 患者的同胞患病风险比普通人群高十多倍。最近的全基因组关联研究一致确定了几个遗传易感性位点。这些位点与其他慢性炎症性疾病的易感性位点重叠程度相当,为转移发病机制知识和潜在的治疗方法提供了有趣的机会。在本文中,我们总结了 PSC 遗传学的现有知识,特别强调了主要组织相容性复合体(MHC)。我们讨论了风险位点的临床相关性,并详细阐述了从相关炎症性疾病和现有的小鼠敲除模型中获得的见解。